XML 36 R20.htm IDEA: XBRL DOCUMENT v3.25.3
Biological assets
12 Months Ended
Jun. 30, 2025
Biological assets  
Biological assets

14.        Biological assets

 

Changes in the Group’s biological assets and their allocation to the fair value hierarchy for the years ended June 30, 2025 and 2024 were as follows:

 

 

 

Agricultural business

 

 

 

Sown land-crops

 

 

Sugarcane fields

 

 

Breeding cattle and cattle for sale (i)

 

 

Other cattle (i)

 

 

Others

 

 

Total

 

 

 

Level 1

 

 

Level 3

 

 

Level 3

 

 

Level 2

 

 

Level 2

 

 

Level 1

 

 

Level 1

 

Balance as of June 30, 2023

 

 

46,076

 

 

 

8,987

 

 

 

32,457

 

 

 

56,047

 

 

 

870

 

 

 

594

 

 

 

145,031

 

Non-current (Production)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

46,847

 

 

 

761

 

 

 

590

 

 

 

48,198

 

Current (Consumable)

 

 

46,076

 

 

 

8,987

 

 

 

32,457

 

 

 

9,200

 

 

 

109

 

 

 

4

 

 

 

96,833

 

Balance as of June 30, 2023

 

 

46,076

 

 

 

8,987

 

 

 

32,457

 

 

 

56,047

 

 

 

870

 

 

 

594

 

 

 

145,031

 

Transfers

 

 

(3,486)

 

 

3,486

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Purchases

 

 

-

 

 

 

-

 

 

 

-

 

 

 

10,348

 

 

 

10

 

 

 

-

 

 

 

10,358

 

Initial recognition and changes in the fair value of biological assets (i)

 

 

-

 

 

 

12,857

 

 

 

4,432

 

 

 

(8,725)

 

 

(427)

 

 

-

 

 

 

8,137

 

Decrease due to harvest

 

 

-

 

 

 

(236,452)

 

 

(69,427)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(305,879)

Sales

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(28,397)

 

 

(50)

 

 

-

 

 

 

(28,447)

Consumptions

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(125)

 

 

(3)

 

 

(129)

 

 

(257)

Costs for the year

 

 

21,748

 

 

 

235,623

 

 

 

65,099

 

 

 

24,206

 

 

 

-

 

 

 

81

 

 

 

346,757

 

Foreign exchange

 

 

(42,690)

 

 

(5,271)

 

 

(5,635)

 

 

(1,770)

 

 

-

 

 

 

-

 

 

 

(55,366)

Balance as of June 30, 2024

 

 

21,648

 

 

 

19,230

 

 

 

26,926

 

 

 

51,584

 

 

 

400

 

 

 

546

 

 

 

120,334

 

Non-current (Production)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

38,228

 

 

 

304

 

 

 

541

 

 

 

39,073

 

Current (Consumable)

 

 

21,648

 

 

 

19,230

 

 

 

26,926

 

 

 

13,356

 

 

 

96

 

 

 

5

 

 

 

81,261

 

Balance as of June 30, 2024

 

 

21,648

 

 

 

19,230

 

 

 

26,926

 

 

 

51,584

 

 

 

400

 

 

 

546

 

 

 

120,334

 

Purchases

 

 

-

 

 

 

-

 

 

 

-

 

 

 

20,919

 

 

 

35

 

 

 

-

 

 

 

20,954

 

Transfers

 

 

(3,205)

 

 

3,205

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Initial recognition and changes in the fair value of biological assets (i)

 

 

-

 

 

 

3,443

 

 

 

8,724

 

 

 

6,941

 

 

 

441

 

 

 

-

 

 

 

19,549

 

Decrease due to harvest

 

 

-

 

 

 

(200,126)

 

 

(73,417)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(273,543)

Sales

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(37,376)

 

 

(23)

 

 

-

 

 

 

(37,399)

Consumes

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(119)

 

 

(2)

 

 

(368)

 

 

(489)

Costs for the year

 

 

2,362

 

 

 

215,887

 

 

 

66,361

 

 

 

28,916

 

 

 

-

 

 

 

436

 

 

 

313,962

 

Currency translation adjustment

 

 

(11,883)

 

 

(352)

 

 

(1,041)

 

 

(857)

 

 

-

 

 

 

-

 

 

 

(14,133)

Balance as of June 30, 2025

 

 

8,922

 

 

 

41,287

 

 

 

27,553

 

 

 

70,008

 

 

 

851

 

 

 

614

 

 

 

149,235

 

Non-current (Production)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

42,207

 

 

 

737

 

 

 

609

 

 

 

43,553

 

Current (Consumable)

 

 

8,922

 

 

 

41,287

 

 

 

27,553

 

 

 

27,801

 

 

 

114

 

 

 

5

 

 

 

105,682

 

Balance as of June 30, 2025

 

 

8,922

 

 

 

41,287

 

 

 

27,553

 

 

 

70,008

 

 

 

851

 

 

 

614

 

 

 

149,235

 

(i)    Biological assets with a production cycle of more than one year (that is, cattle) generated “Initial recognition and changes in fair value of biological assets” amounting to ARS 7,382 and ARS (9,152) for the fiscal years ended June 30, 2025 and 2024, respectively. For the fiscal years ended June 30, 2025 and 2024, amounts of ARS 8,103 and ARS (5,588), was attributable to price changes, and amounts of ARS (721) and ARS (3,564), was attributable to physical changes generated by production result, respectively.

 

Crops and oilseeds

 

The Group’s crops generally include crops and oilseeds (corn, wheat, soybean and sunflower) as well as peanut. The Group measures biological assets that have attained significant biological growth at fair value less costs to sell. The Group measures biological assets that have not attained significant biological growth or when the impact of biological transformation on price is not expected to be material, at cost less any impairment losses, which approximates fair value.

Sugarcane

 

The Group’s sugarcane production is based in Brazil and to a lesser extent in Bolivia. This crop’s production requires specific weather conditions (tropical and subtropical climates. The Group recognizes these crops at a fair value net of costs of sales as soon as the biological transformation of the bearer plant is observed.

 

Fair value of biological assets

 

When an active market exists for biological assets, the Group uses the quoted market price in the principal market as a basis to determine the fair value of its biological assets. Live cattle is measured at fair value less cost to sell, based on market quoted at an auction involving cattle of the same age, breed and genetic merit adjusted, if applicable, to reflect any difference. When there is no active market or market-determined prices are not available, (for example, unharvested crops with significant growth or growing agricultural produce of sugarcane), the Group determines the fair value of a biological asset based on discounted cash flows models.

 

These models require the input of highly subjective assumptions including observable and unobservable data. The not observable information is determined based on the best information available for example, by reference to historical information of past practices and results, statistics and agricultural information and other analytical techniques. Key assumptions utilized in this method include future market prices, estimated yields at the point of harvest and estimated future costs of harvesting and other costs.

Market prices are generally determined by reference to observable data in the principal market for the agricultural produce. Harvesting costs and other costs are estimated based on historical and statistical data. Yields are estimated based on several factors including the location of the farmland and soil type, environmental conditions, infrastructure and other restrictions and growth at the time of measurement. Yields are subject to a high degree of uncertainty and may be affected by several factors out of the Group’s control including but not limited to extreme or unusual weather conditions, plagues and other crop diseases.

 

The key assumptions discussed above are highly sensitive. Reasonable shifts in assumptions including but not limited to increases or decreases in prices, costs and discount factors used may result in a significant increase or decrease to the fair value of biological assets recognized at any given time. Cash flows are projected based on estimated production. Estimates of production in themselves are dependent on various assumptions, in addition to those described above, including but not limited to several factors such as location, environmental conditions and other restrictions. Changes in these estimates could materially impact on estimated production, and could therefore affect estimates of future cash flows used in the assessment of fair value. The valuation models and their assumptions are reviewed periodically, and, if necessary, adjusted.

 

As of June 30 of each year, the Group’s biological assets that are subject to a valuation model include unharvested crops and sugarcane plantations.

 

The fair value less estimated selling costs of agricultural produce at the point of harvest amount to ARS (212,444) and ARS (222,766) for the years ended June 30, 2025 and 2024, respectively.

 

When no quoted prices are available in an active market, the Group uses a range of valuation models. The following table presents main parameters:

 

Description

Valuation technique

 Parameters

 Range 

Cattle (Level 2)

Comparable market prices

Price per livestock head/kg and per category

-

Sown land-crops  (Level 3)

Discounted cash flows

Yields - Operating costs - Selling expenses - Future of sale prices - Discount rate

Argentina

Yields: 0.62 - 15.33 Tn/ha

Future of sale prices:  211,612 - 723,937 ARS/Tn

Operating cost: 72,159 - 530,375 ARS/ha

Brazil:

Yields: 101.6 Sacas/ha

Future of sale prices: 43.84 BRL/tn

Operating cost: 11.45 BRL/ha.

Sugarcane fields (Level 3)

Discounted cash flows

Yields - Operating costs - Selling expenses - Future of sale prices - Discount rate

Brazil:

Yields: 83.17 tn/ha

Future of sale prices: 133.79 BRL/tn.

Operating cost: 77.94 BRL/tn.

 

As of June 30, 2025 and 2024, the better and maximum use of biological assets shall not significantly differ from the current use.

 

Capitalized cost of production as of June 30, 2025, 2024 and 2023 are as follows:

 

 

 

 06.30.2025

 

 

 06.30.2024

 

 

 06.30.2023

 

Supplies and labors

 

 

226,034

 

 

 

256,466

 

 

 

268,886

 

Salaries, social security costs and other personnel expenses

 

 

15,232

 

 

 

17,158

 

 

 

16,109

 

Depreciation and amortization

 

 

47,617

 

 

 

44,809

 

 

 

47,364

 

Fees and payments for services

 

 

1,318

 

 

 

1,038

 

 

 

708

 

Maintenance, security, cleaning, repairs and others

 

 

2,363

 

 

 

2,517

 

 

 

2,268

 

Taxes, rates and contributions

 

 

526

 

 

 

338

 

 

 

487

 

Leases and service charges

 

 

254

 

 

 

200

 

 

 

176

 

Freights

 

 

2,814

 

 

 

1,899

 

 

 

2,476

 

Travelling, library expenses and stationery

 

 

1,992

 

 

 

1,890

 

 

 

1,832

 

Other expenses

 

 

15,376

 

 

 

20,361

 

 

 

17,784

 

 

 

 

313,526

 

 

 

346,676

 

 

 

358,090